-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on Evogene, Lowers Price Target to $3.5

Benzinga·05/22/2025 15:53:32
Listen to the news
Lake Street analyst Ben Klieve maintains Evogene (NASDAQ:EVGN) with a Buy and lowers the price target from $5 to $3.5.